ethyl 2-((N-(p-methoxybenzyl)sulfamoyl)amino)acetate → 2-(4-Methoxybenzyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxide

HRID 16969

반응식

HRID 16969 반응식
[CH3:1][O:2][C:3]1[CH:20]=[CH:19][C:6]([CH2:7][NH:8][S:9]([NH:12][CH2:13][C:14](OCC)=[O:15])(=[O:11])=[O:10])=[CH:5][CH:4]=1.O(C(C)(C)C)[K]>CN(C=O)C>[CH3:1][O:2][C:3]1[CH:20]=[CH:19][C:6]([CH2:7][N:8]2[C:14](=[O:15])[CH2:13][NH:12][S:9]2(=[O:11])=[O:10])=[CH:5][CH:4]=1

참가 물질

4

반응물 2

HCID 18449916ethyl 2-((N-(p-methoxybenzyl)sulfamoyl)amino)acetateHCID 178418922HCID 178418922, 화합물

생성물 1

HCID 588428642-(4-Methoxybenzyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxide수율 54%

시약·촉매·용매 1

HCID 6228Dimethylformamide용매

실험 절차

To a solution of ethyl 2-((N-(p-methoxybenzyl)sulfamoyl)amino)acetate from the previous step (1.0 g, 3.47 mmol) in DMF (50 mL) was added KO-t-Bu (1.56 g, 13.88 mmol) in portions under N2 atmosphere at RT. The mixture was stirred overnight then quenched with HCl/methanol (2 M). After the solvent was removed in vacuo, the residue was washed with water to afford 2-(4-methoxy-benzyl)-1,1-dioxo-1λ6-[1,2,5]thiadiazolidin-3-one (480 mg, 54%). 1H-NMR (CDCl3): δ 7.36 (d, J=8.4 Hz, 2H), 6.87 (d, J=8.8 Hz, 2H), 4.87 (m, 1H), 4.68 (s, 2H), 4.03 (d, J=7.2 Hz, 2H), 3.80 (s, 3H).

후처리

  1. customthen quenched with HCl/methanol (2 M)
  2. customAfter the solvent was removed in vacuo
  3. washthe residue was washed with water

출처 및 근거

ORD 기록
ord-bf3a4e0577384e76a1c67d7e38daef07
출처 데이터셋
uspto-grants-2010_06
특허 번호
US07737283B2

연결된 노트

불러오는 중…